Vaccines (Jan 2023)

Ageing Curtails the Diversity and Functionality of Nascent CD8<sup>+</sup> T Cell Responses against SARS-CoV-2

  • Davide Proietto,
  • Beatrice Dallan,
  • Eleonora Gallerani,
  • Valentina Albanese,
  • Sian Llewellyn-Lacey,
  • David A. Price,
  • Victor Appay,
  • Salvatore Pacifico,
  • Antonella Caputo,
  • Francesco Nicoli,
  • Riccardo Gavioli

DOI
https://doi.org/10.3390/vaccines11010154
Journal volume & issue
Vol. 11, no. 1
p. 154

Abstract

Read online

Age-related changes in the immune system are thought to underlie the vulnerability of elderly individuals to emerging viral diseases, such as coronavirus disease 2019 (COVID-19). In this study, we used a fully validated in vitro approach to determine how age impacts the generation of de novo CD8+ T cell responses against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of COVID-19. Our data revealed a generalized deficit in the ability of elderly individuals to prime the differentiation of naïve precursors into effector CD8+ T cells defined by the expression of interferon (IFN)-γ and the transcription factor T-bet. As a consequence, there was an age-related decline in the diversity of newly generated CD8+ T cell responses targeting a range of typically immunodominant epitopes derived from SARS-CoV-2, accompanied by an overall reduction in the expression frequency of IFN-γ. These findings have potential implications for the development of new strategies to protect the elderly against COVID-19.

Keywords